标题/作者	年份
Coronavirus biology and replication: implications for SARS-CoV-2 P V’kovski, A Kratzel, S Steiner, H Stalder, V Thiel Nature Reviews Microbiology 19 (3), 155-170	2021
The architecture of SARS-CoV-2 transcriptome D Kim, JY Lee, JS Yang, JW Kim, VN Kim, H Chang Cell 181 (4), 914-921. e10	2020
Nanopore sequencing technology, bioinformatics and applications Y Wang, Y Zhao, A Bollas, Y Wang, KF Au Nature biotechnology 39 (11), 1348-1365	2021
Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein AD Davidson, MK Williamson, S Lewis, D Shoemark, MW Carroll, ... Genome medicine 12 (1), 1-15	2020
Nanopore targeted sequencing for the accurate and comprehensive detection of SARS‐CoV‐2 and other respiratory viruses M Wang, A Fu, B Hu, Y Tong, R Liu, Z Liu, J Gu, B Xiang, J Liu, W Jiang, ... Small 16 (32), 2002169	2020
The coronavirus proofreading exoribonuclease mediates extensive viral recombination J Gribble, LJ Stevens, ML Agostini, J Anderson-Daniels, JD Chappell, ... PLoS pathogens 17 (1), e1009226	2021
Structures and functions of coronavirus replication–transcription complexes and their relevance for SARS-CoV-2 drug design B Malone, N Urakova, EJ Snijder, EA Campbell Nature Reviews Molecular Cell Biology 23 (1), 21-39	2022
On the origin and evolution of SARS-CoV-2 D Singh, SV Yi Experimental & Molecular Medicine 53 (4), 537-547	2021
Detection of plant viruses and disease management: Relevance of genetic diversity and evolution L Rubio, L Galipienso, I Ferriol Frontiers in plant Science 11, 1092	2020
Next generation sequencing of SARS-CoV-2 genomes: challenges, applications and opportunities M Chiara, AM D’Erchia, C Gissi, C Manzari, A Parisi, N Resta, F Zambelli, ... Briefings in Bioinformatics 22 (2), 616-630	2021
Mapping the epigenetic modifications of DNA and RNA LY Zhao, J Song, Y Liu, CX Song, C Yi Protein & cell 11 (11), 792-808	2020
Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy E Wyler, K Mösbauer, V Franke, A Diag, LT Gottula, R Arsiè, F Klironomos, ... IScience 24 (3), 102151	2021
Direct RNA sequencing and early evolution of SARS-CoV-2 G Taiaroa, D Rawlinson, L Featherstone, M Pitt, L Caly, J Druce, D Purcell, ... BioRxiv, 2020.03. 05.976167	2020
Nanopore sequencing and its application to the study of microbial communities L Ciuffreda, H Rodríguez-Pérez, C Flores Computational and structural biotechnology journal 19, 1497-1511	2021
New twists in detecting mRNA modification dynamics I Anreiter, Q Mir, JT Simpson, SC Janga, M Soller Trends in Biotechnology 39 (1), 72-89	2021
Bulk and single-cell gene expression profiling of SARS-CoV-2 infected human cell lines identifies molecular targets for therapeutic intervention W Emanuel, M Kirstin, F Vedran, D Asija, GL Theresa, A Roberto, ... BioRxiv, 2020.05. 05.079194	2020
Loop‐mediated isothermal amplification (LAMP): an effective molecular point‐of‐care technique for the rapid diagnosis of coronavirus SARS‐CoV‐2 M Chaouch Reviews in medical virology 31 (6), e2215	2021
Perspectives and benefits of high-throughput long-read sequencing in microbial ecology L Tedersoo, M Albertsen, S Anslan, B Callahan Applied and environmental microbiology 87 (17), e00626-21	2021
The epigenetic implication in coronavirus infection and therapy S Atlante, A Mongelli, V Barbi, F Martelli, A Farsetti, C Gaetano Clinical Epigenetics 12, 1-12	2020
Characterisation of the transcriptome and proteome of SARS-CoV-2 using direct RNA sequencing and tandem mass spectrometry reveals evidence for a cell passage induced in-frame deletion in the spike glycoprotein that removes the furin-like cleavage site AD Davidson, MK Williamson, S Lewis, D Shoemark, MW Carroll, ... BioRxiv, 2020.03. 22.002204	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。